Berikutnya

Putar otomatis

ER+/HER2+ Metastatic Breast Cancer

2 Tampilan • 07/03/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis